TP53 and breast carcinoma: Pharmacological activation of p53 in the colorectal cancer HCT116 cell lines and the breast cancer MCF7 cell lines has been observed to inhibit the expression of the MHC I molecules HLA-A, B, and C. It has been shown that the reduced expression of MHC I molecules promotes the killing of target cells by NK cells (43).